Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology – a prospective study-Reference-Cited by-同舟云学术

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology – a prospective study

Published:2017-12 Issue:1 Volume:17 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Chaminda Siriwardana Rohan,Suchintha Thilakarathne,Anuk Niriella Madunil,Supun Dassanayake Anuradha,Bhagya Gunathilake Mahen,Habarakada Liyanage Chandika Anuruddha,Janaka De Silva Hithadurage

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12876-017-0710-x.pdf

Reference20 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

2. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22(33):5093–107.

3. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15(Suppl 4):14–22.

4. Blum HE, Moradpour D. Viral pathogenesis of hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17(Suppl 3):S413–20.

5. Siriwardana RCLCAH, Gunethileke MB. Hepatocellular carcinoma in Sri Lanka - where do we stand? The Sri Lanka journal of. Surgery. 2013;31(2)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma;BMC Medical Imaging;2023-09-22

2. Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-01

3. Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?;World Journal of Hepatology;2022-06-27

4. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken;Journal of Clinical and Experimental Hepatology;2021-11

5. Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study;Chinese Journal of Cancer Research;2019